Abstract
Bone marrow pathologies cover a very wide group of diseases. For the correct diagnosis of bone marrow diseases, knowing the normal appearance of the bone marrow and recognizing the radiological findings of these diseases play a key role. In this article, we aimed to present the imaging findings of normal and pathological bone marrow.
Keywords: Bone marrow, MRI, hematopoietic, multiple myeloma, T1-weighted imaging, vertebrae
References
Vande Berg BC, Malghem J, Lecouvet FE, Maldague B. Classification and detection of bone marrow lesions with magnetic resonance imaging.Skeletal Radiol. 1998; 27: 529-45.
Shah LM, Hanrahan CJ. MRI of spinal bone marrow: part I, techniques and normal age-related appearances.AJR Am J Roentgenol. 2011; 197: 1298-308.
Ishijima H, Ishizaka H, Horikoshi H, Sakurai M. Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex.AJR Am J Roentgenol. 1996; 167: 355-8.
Carroll KW, Feller JF, Tirman PF. Useful internal standards for distinguishing infiltrative marrow pathology from hematopoietic marrow at MRI.J Magn Reson Imaging.1997; 7: 394-8.
Torkian P, Mansoori B, Hillengass J, Azadbakht J, Rashedi S, Lee SS, et al. Diffusion-weighted imaging (DWI) in diagnosis, staging, and treatment response assessment of multiple myeloma: a systematic review and meta-analysis.Skeletal Radiol. 2023; 52: 565-83.
Paternain A, García-Velloso MJ, Rosales JJ, Ezponda A, Soriano I, Elorz M, et al. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with (18)F-FDG PET-CT.Eur J Radiol. 2020; 133: 109403.
Mossa-Basha M, Gerszten PC, Myrehaug S, Mayr NA, Yuh WT, Jabehdar Maralani P, et al. Spinal metastasis: diagnosis, management and follow-up.Br J Radiol. 2019; 92: 20190211.
Shellock FG, Morris E, Deutsch AL, Mink JH, Kerr R, Boden SD. Hematopoietic bone marrow hyperplasia: high prevalence on MR images of the knee in asymptomatic marathon runners.AJR Am J Roentgenol. 1992; 158: 335-8.
Poulton TB, Murphy WD, Duerk JL, Chapek CC, Feiglin DH. Bone marrow reconversion in adults who are smokers: MR imaging findings.AJR Am J Roentgenol. 1993; 161: 1217-21.
Hajimoradi M, Haseli S, Abadi A, Chalian M. Musculoskeletal imaging manifestations of beta-thalassemia.Skeletal Radiol. 2021; 50: 1749-62.
Fraenkel PG. Anemia of inflammation: a review.Med Clin N Am. 2017; 101: 285-96.
Tsujikawa T, Oikawa H, Tasaki T, Hosono N, Tsuyoshi H, Rahman MGM, et al. Integrated [F]FDG PET/MRI demonstrates the iron-related bone-marrow physiology. Sci Rep. 2020; 10: 13878.
Stäbler A, Doma AB, Baur A, Krüger A, Reiser MF. Reactive bone marrow changes in infectious spondylitis: quantitative assessment with MR imaging.Radiology. 2000; 217: 863-8. Erratum in: Radiology.2001; 219: 300.
Ciray I, Lindman H, Aström GK, Wanders A, Bergh J, Ahlström HK. Effect of granulocyte colony-stimulating factor (G-CSF)-supported chemotherapy on MR imaging of normal red bone marrow in breast cancer patients with focal bone metastases.Acta Radiol. 2003; 44: 472-84.
Hollinger EF, Alibazoglu H, Ali A, Green A, Lamonica G. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging.Clin Nucl Med. 1998; 23: 93-8.
Minutoli F, Pergolizzi S, Blandino A, Mormina E, Amato E, Gaeta M. Effect of granulocyte colony-stimulating factor on bone marrow: evaluation by intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging.Radiol Med. 2020; 125: 280-7.
Chow LT, Ng AW, Wong SK. Focal nodular and diffuse haematopoietic marrow hyperplasia in patients with underlying malignancies: a radiological mimic of malignancy in need of recognition.Clin Radiol. 2017; 72: 265.
Hanrahan CJ, Shah LM. MRI of spinal bone marrow: part 2, T1-weighted imaging-based differential diagnosis.AJR Am J Roentgenol. 2011; 197: 1309-21.
Vande Berg BC, Kirchgesner T, Acid S, Malghem J, Vekemans MC, Lecouvet FE. Diffuse vertebral marrow changes at MRI: multiple myeloma or normal?Skeletal Radiol. 2022; 51: 89-99.
Ehresman J, Pennington Z, Schilling A, Lubelski D, Ahmed AK, Cottrill E, et al. Novel MRI-based score for assessment of bone density in operative spine patients.Spine J. 2020; 20: 556-62.
Ricci C, Cova M, Kang YS, Yang A, Rahmouni A, Scott WW Jr, et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study.Radiology. 1990; 177: 83-8.
Travlos GS. Normal structure, function, and histology of the bone marrow.Toxicol Pathol. 2006; 34: 548-65.
Levine CD, Schweitzer ME, Ehrlich SM. Pelvic marrow in adults.Skelet Radiol. 1994; 23: 343-7.
Schweitzer ME, Levine C, Mitchell DG, Gannon FH, Gomella LG. Bull’s-eyes and halos: useful MR discriminators of osseous metastases.Radiology.1993; 188: 249-52.
Zhao J, Krug R, Xu D, Lu Y, Link TM. MRI of the spine: image quality and normal-neoplastic bone marrow contrast at 3 T versus 1.5 T.AJR Am J Roentgenol.2009; 192: 873-80.
Hildenbrand N, Klein A, Maier-Hein K, Wennmann M, Delorme S, Goldschmidt H, et al. Identification of focal lesion characteristics in MRI which indicate presence of corresponding osteolytic lesion in CT in patients with multiple myeloma.Bone. 2023; 175: 116857.
Chakraborty R, Hillengass J, Lentzsch S. How do we image patients with multiple myeloma and precursor states?Br J Haematol. 2023; 203: 536-45.
Wu F, Bernard S, Fayad LM, Ilaslan H, Messiou C, Moulopoulos LA, et al. Updates and ongoing challenges in imaging of multiple myeloma: AJR expert panel narrative review.AJR Am J Roentgenol. 2021; 217: 775-85.
Hillengass J, Bäuerle T, Bartl R, Andrulis M, McClanahan F, Laun FB, et al. Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology.Br J Haematol. 2011; 153: 721-8. Erratum in: Br J Haematol.2011; 155: 281.
Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple myeloma.Leukemia. 2006; 20: 1467-73. Erratum in: Leukemia.2006; 20: 2220. Erratum in:Leukemia. ; 21: 1134.
Messiou C, Porta N, Sharma B, Levine D, Koh DM, Boyd K, et al. Prospective evaluation of whole-body MRI versus FDG PET/CT for lesion detection in participants with myeloma.Radiol Imaging Cancer. 2021; 3: e210048.
Westerland O, Amlani A, Kelly-Morland C, Fraczek M, Bailey K, Gleeson M, et al. Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.Eur J Nucl Med Mol Imaging. 2021; 48: 2558-65.
Moulopoulos LA, Dimopoulos MA, Kastritis E, Christoulas D, Gkotzamanidou M, Roussou M, et al. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.Am J Hematol. 2012; 87: 861-4.
Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD Jr, et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.J Clin Oncol. 2007; 25: 1121-8.
Rasche L, Angtuaco EJ, Alpe TL, Gershner GH, McDonald JE, Samant RS, et al. The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.Blood. 2018; 132: 59-66.
Merz M, Hielscher T, Wagner B, Sauer S, Shah S, Raab MS, et al. Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma.Leukemia. 2014; 28: 1902-8.
Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.Lancet Oncol. 2014; 15: 538-48.
Hillengass J, Fechtner K, Weber MA, Bäuerle T, Ayyaz S, Heiss C, et al. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.J Clin Oncol. 2010; 28: 1606-10.
Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.Lancet Oncol. 2016; 17: 328-46.
Rama S, Suh CH, Kim KW, Durieux JC, Ramaiya NH, Tirumani SH. Comparative performance of whole-body MRI and FDG PET/CT in evaluation of multiple myeloma treatment response: systematic review and meta-analysis.AJR Am J Roentgenol. 2022; 218: 602-13.
Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS).Radiology. 2019; 291: 5-13.
Jassens AM, Offner FC, Van Hove WZ. Bone marrow necrosis.Cancer.2000; 88: 1769-80.
Tang YM, Jeavons S, Stuckey S, Middleton H, Gill D. MRI features of bone marrow necrosis.AJR Am J Roentgenol. 2007; 188: 509-14.
Murakami H, Kawahara N, Gabata T, Nambu K, Tomita K. Vertebral body osteonecrosis without vertebral collapse.Spine (Phila Pa 1976). ; 28: 323-8.
Udby PM, Samartzis D, Carreon LY, Andersen MØ, Karppinen J, Modic M. A definition and clinical grading of Modic changes.J Orthop Res. 2022; 40: 301-7.
Udby PM, Bendix T, Ohrt-Nissen S, Lassen MR, Sørensen JS, Brorson S, et al. Modic changes are not associated with long-term pain and disability: a cohort study with 13-year follow-up.Spine (Phila Pa 1976). 2019; 44: 1186-92.
Herlin C, Kjaer P, Espeland A, Skouen JS, Leboeuf-Yde C, Karppinen J, et al. Modic changes-their associations with low back pain and activity limitation: a systematic literature review and meta-analysis.PLoS One. 2018 ;13: e0200677.
Saukkonen J, Määttä J, Oura P, Kyllönen E, Tervonen O, Niinimäki J, et al. Association between Modic changes and low back pain in middle age: a Northern Finland Birth Cohort study.Spine (Phila Pa 1976). 2020; 45: 1360-7.
Weishaupt D, Zanetti M, Hodler J, Min K, Fuchs B, Pfirrmann CW, et al. Painful lumbar disk derangement: relevance of endplate abnormalities at MR imaging.Radiology. 2001; 218: 420-7.
Laustsen AF, Bech-Azeddine R. Do Modic changes have an impact on clinical outcome in lumbar spine surgery? a systematic literature review.Eur Spine J. 2016; 25: 3735-45.
Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging.Radiology. 1988; 166: 193-9.
Pastushyn AI, Slin’ko EI, Mirzoyeva GM. Vertebral hemangiomas: diagnosis, management, natural history and clinicopathological correlates in 86 patients.Surg Neurol. 1998; 50: 535-47.
Zafeiris CP, Lewkonia P, Jacobs WB. Atypical vertebral hemangioma: an aggressive form of a benign disease. Case report and literature review.J Musculoskelet Neuronal Interact. 2021; 21: 317-21.
Jiang L, Liu XG, Yuan HS, Yang SM, Li J, Wei F, et al. Diagnosis and treatment of vertebral hemangiomas with neurologic deficit: a report of 29 cases and literature review.Spine J. 2014; 14: 944-54.
Morales KA, Arevalo-Perez J, Peck KK, Holodny AI, Lis E, Karimi S. Differentiating atypical hemangiomas and metastatic vertebral lesions: the role of T1-weighted dynamic contrast-enhanced MRI.AJNR Am J Neuroradiol. 2018; 39: 968-97.
Cao J, Gao S, Zhang C, Zhang Y, Sun W, Cui L. Differentiating atypical hemangiomas and vertebral metastases: a field-of-view (FOV) and FOCUS intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) study.Eur Spine J. 2020; 29: 3187-93.
van Vucht N, Santiago R, Pressney I, Saifuddin A. Anomalous signal intensity increase on out-of-phase chemical shift imaging: a manifestation of marrow mineralisation?Skeletal Radiol. 2020; 49: 1269-75.
Paladino LP, Belzarena AC, Henderson-Jackson E, Joyce DM. Metastatic vertebral lesion mimicking an atypical hemangioma with negative 18F-FDG positron emission tomography-computed tomography.Radiol Case Rep. 2019; 14: 1401-6.
Hegde G, Azzopardi C, Davies AM, Patel A, James SL, Botchu R. Spinal collision lesions. J Clin Orthop Trauma. 2021; 19:21-25.
Stevens SK, Moore SG, Kaplan ID. Early and late bone-marrow changes after irradiation: MR evaluation.AJR Am J Roentgenol. 1990; 154: 745-50.
Kim NR, Choi JY, Hong SH, Jun WS, Lee JW, Choi JA, et al. “MR corner sign”: value for predicting presence of ankylosing spondylitis.AJR Am J Roentgenol. 2008; 191: 124-8.
Sheldon PJ, Forrester DM. Imaging of amyloid arthropathy.Semin Musculoskelet Radiol. 2003; 7: 195-203.
Parmar H, Rath T, Castillo M, Gandhi D. Imaging of focal amyloid depositions in the head, neck, and spine: amyloidoma.AJNR Am J Neuroradiol. 2010; 31: 1165-70.
Mirowitz SA. Hematopoietic bone marrow within the proximal humeral epiphysis in normal adults: investigation with MR imaging.Radiology. 1993; 188: 689-93.
Adhikari P, Khadka S, Regmi PR, Shrestha A, Panta BR, Bhandari S, et al. Primary spinal non-Hodgkin lymphoma presenting as impending cauda equina syndrome: a case report.Ann Med Surg (Lond). 2022; 83: 104696.
Moussaly E, Nazha B, Zaarour M, Atallah JP. Primary non-Hodgkin’s lymphoma of the spine: a case report and literature review.World J Oncol. 2015; 65: 459-63.
Rodríguez-Laval V, Lumbreras-Fernández B, Aguado-Bueno B, Gómez-León N. Imaging of multiple myeloma: present and future. J Clin Med. 2024; 13: 264.
